The effect of lidocaine on PpIX photobleaching and outcome of ALA-PDT in vitro

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 4, 2007, Pages 249-253

  Mikolajewska, Patrycja ^a   Juzeniene, Asta ^a   Moan, Johan ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Lidocaine; Photobleaching; Photodynamic therapy; Singlet oxygen

Indexed keywords

AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE; LIDOCAINE; PROTOPORPHYRIN;

ARTICLE; BLEACHING; COLONY FORMING UNIT; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LIGHT EXPOSURE; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 36448983269     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2007.10.002     Document Type: Article

References (42)

1. Juzeniene A., Nielsen K.P., and Moan J. Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol 25 (2006) 7-28
2. Triesscheijn M., Baas P., Schellens J.H., and Stewart F.A. Photodynamic therapy in oncology. Oncologist 11 (2006) 1034-1044
3. Braathen L.R., Szeimies R.M., Basset-Seguin N., et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 56 (2007) 125-143
4. Kennedy J.C., and Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14 (1992) 275-292
5. Marcus S.L., Sobel R.S., Golub A.L., Carroll R.L., Lundahl S., and Shulman D.G. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status. J Clin Laser Med Surg 14 (1996) 59-66
6. Kloek J., Akkermans W., and Beijersbergen van Henegouwen G.M. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 67 (1998) 150-154
7. Peng Q., Warloe T., Berg K., et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79 (1997) 2282-2308
8. Washbrook R., and Riley P.A. Comparison of delta-aminolaevulinic acid and its methyl ester as an inducer of porphyrin synthesis in cultured cells. Br J Cancer 75 (1997) 1417-1420
9. Casas A., and Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr Med Chem Anticancer Agents 2 (2002) 465-475
10. Borelli C., Herzinger T., Merk K., et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg 33 (2007) 314-318
11. Ericson M.B., Sandberg C., Stenquist B., et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 151 (2004) 1204-1212
12. Grapengiesser S., Ericson M., Gudmundsson F., Larko O., Rosen A., and Wennberg A.M. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 27 (2002) 493-497
13. Holmes M.V., Dawe R.S., Ferguson J., and Ibbotson S.H. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 150 (2004) 337-340
14. Kasche A., Luderschmidt S., Ring J., and Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 5 (2006) 353-356
15. Radakovic-Fijan S., Blecha-Thalhammer U., Kittler H., Honigsmann H., and Tanew A. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 53 (2005) 823-827
16. Sandberg C., Stenquist B., Rosdahl I., et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 86 (2006) 404-408
17. Skiveren J., Haedersdal M., Philipsen P.A., Wiegell S.R., and Wulf H.C. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol 86 (2006) 409-411
18. Brown S.B., Shillcock M., and Jones P. Equilibrium and kinetic studies of the aggregation of porphyrins in aqueous solution. Biochem J 153 (1976) 279-285
19. van Oosten E.J., Kuijpers D.I.M., and Thissen M.R.T.M. Different pain sensations in photodynamic therapy of nodular basal cell carcinoma: results from a prospective trial and a review of the literature. Photodiagn Photodyn Therapy 3 (2006) 61-68
20. Wennberg A.M. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol 46 (2005) S3-S4 Suppl
21. Wiegell S.R., Stender I.M., Na R., and Wulf H.C. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 139 (2003) 1173-1177
22. Algermissen B., Osterloh D., Philipp C.M., and Berlien H.-P. Management of ALA-PDT induced pain sensations. Med Laser Appl 18 (2003) 57-64
23. Arildsson M., Asker C.L., Salerud E.G., and Stromberg T. Skin capillary appearance and skin microvascular perfusion due to topical application of analgesia cream. Microvasc Res 59 (2000) 14-23
24. Cairnduff F., Stringer M.R., Hudson E.J., Ash D.V., and Brown S.B. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69 (1994) 605-608
25. Haller J.C., Cairnduff F., Slack G., et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 143 (2000) 1270-1275
26. Langan S.M., and Collins P. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2. 5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 154 (2006) 146-149
27. Shackley D.C., Briggs C., Gilhooley A., et al. Photodynamic therapy for superficial bladder cancer under local anaesthetic. BJU Int 89 (2002) 665-670
28. Touma D., Yaar M., Whitehead S., Konnikov N., and Gilchrest B.A. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 140 (2004) 33-40
29. Das K.C., and Misra H.P. Lidocaine: a hydroxyl radical scavenger and singlet oxygen quencher. Mol Cell Biochem 115 (1992) 179-185
30. Zanocco A.L., Lemp E., Pizarro N., de la Fuente J.R., and Gunther G. Solvent effects on the sensitized photoxygenation of lidocaine. J Photochem Photobiol A: Chem 140 (2001) 109-115
31. Weishaupt K.R., Gomer C.J., and Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36 (1976) 2326-2329
32. Noguchi P., Wallace R., Johnson J., et al. Characterization of the WIDR: a human colon carcinoma cell line. In Vitro 15 (1979) 401-408
33. Dietel W., and Wendenburg R. The phototransformation of ALA-induced protoporphyrin IX (PPIX) in carcinoma cells and of exogenous PPIX in cells and solutions. Proc SPIE 2371 (1995) 567-571
34. Strauss W.S., Sailer R., Gschwend M.H., Emmert H., Steiner R., and Schneckenburger H. Selective examination of plasma membrane-associated photosensitizers using total internal reflection fluorescence spectroscopy: correlation between photobleaching and photodynamic efficacy of protoporphyrin IX. Photochem Photobiol 67 (1998) 363-369
35. Dysart J.S., and Patterson M.S. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions. Photochem Photobiol Sci 5 (2006) 73-81
36. Margalit R., Shaklai N., and Cohen S. Fluorimetric studies on the dimerization equilibrium of protoporphyrin IX and its haemato derivative. Biochem J 209 (1983) 547-552
37. Molnar A., Dedic R., Korinek M., Svoboda A., and Hala J. Protoporphyrin IX and hematoporphyrin derivatives interactions with oxygen studied by time and spectral resolved phosphorescence. J Mol Struct (2005) 723-725
38. Arildsson M., Nilsson G.E., and Stromberg T. Effects on skin blood flow by provocation during local analgesia. Microvasc Res 59 (2000) 122-130
39. Bjerring P., Andersen P.H., and rendt-Nielsen L. Vascular response of human skin after analgesia with EMLA cream. Br J Anaesth 63 (1989) 655-660
40. Newton D.J., McLeod G.A., Khan F., and Belch J.J. Mechanisms influencing the vasoactive effects of lidocaine in human skin. Anaesthesia 62 (2007) 146-150
41. Moan J. The photochemical yield of singlet oxygen from porphyrins in different states of aggregation. Photochem Photobiol 39 (1984) 445-449
42. Moan J., and Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 53 (1991) 549-553